OICR Invests in Personalized Medicine Spin-offs

The Toronto-based institute has made investments in a multiplexed biomarker identification tool company and a planned spin-off that is developing a microchip-based rapid diagnostic system.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories